Literature DB >> 8733477

Expansion of mutant stem cell populations in the human colon.

M Bjerknes1.   

Abstract

In general, it is presumed that colonic epithelial stem cells are the principal cell type at risk of incurring the series of somatic mutations leading to carcinoma, since all other epithelial cell types are short-lived. Mutant stem cell clonal expansion increases the risk for subsequent mutations and is therefore a potentially important step in carcinogenesis. The stem cells reside in colonic crypts, simple tubular foldings of the epithelium, and thus counting crypts provides an indirect means to determine stem cell numbers. The normal crypt population is known to expand through a process of crypt replication and this is thought to result in a corresponding expansion of the epithelial stem cell population. A simple mathematical model of the population dynamics of normal and mutant crypts (crypts containing mutant stem cells) is developed and used to estimate a lower bound on the relative rate of expansion of the mutant stem cell population. The model predicts that if mutant and normal crypt populations expand at the same rate, and if the mutation rate is small relative to the rate of growth, then the fraction of clusters of mutant crypts composed of only a single mutant crypt should steadily decrease with age towards one-half. Aberrant crypts are easily recognizable lesions in human colon which have frequently been shown to contain cells with K-ras and occasionally APC gene mutations. Application of the model to recent counts of aberrant crypt cluster sizes indicate that the aberrant crypt population, and the contained mutant stem cell population, is expanding substantially faster than normal.

Entities:  

Mesh:

Year:  1996        PMID: 8733477     DOI: 10.1006/jtbi.1996.0034

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  14 in total

1.  Epithelial stem cell repertoire in the gut: clues to the origin of cell lineages, proliferative units and cancer.

Authors:  N A Wright
Journal:  Int J Exp Pathol       Date:  2000-04       Impact factor: 1.925

Review 2.  Stem cell in gastrointestinal structure and neoplastic development.

Authors:  M Brittan; N A Wright
Journal:  Gut       Date:  2004-06       Impact factor: 23.059

3.  Occult progression by Apc-deficient intestinal crypts as a target for chemoprevention.

Authors:  Jared M Fischer; Arnout G Schepers; Hans Clevers; Darryl Shibata; R Michael Liskay
Journal:  Carcinogenesis       Date:  2013-08-29       Impact factor: 4.944

4.  Crypt dynamics and colorectal cancer: advances in mathematical modelling.

Authors:  I M M van Leeuwen; H M Byrne; O E Jensen; J R King
Journal:  Cell Prolif       Date:  2006-06       Impact factor: 6.831

5.  Simulating mouse mammary gland development: cell ageing and its relation to stem and progenitor activity.

Authors:  A Paguirigan; D J Beebe; C M Alexander
Journal:  Cell Prolif       Date:  2007-02       Impact factor: 6.831

Review 6.  Calcium, a Cell Cycle Commander, Drives Colon Cancer Cell Diffpoptosis.

Authors:  Ahmed A Abd-Rabou
Journal:  Indian J Clin Biochem       Date:  2016-03-30

Review 7.  A review of spatial computational models for multi-cellular systems, with regard to intestinal crypts and colorectal cancer development.

Authors:  Giovanni De Matteis; Alex Graudenzi; Marco Antoniotti
Journal:  J Math Biol       Date:  2012-05-08       Impact factor: 2.259

8.  APC mutation and the crypt cycle in murine and human intestine.

Authors:  M Bjerknes; H Cheng; K Hay; S Gallinger
Journal:  Am J Pathol       Date:  1997-03       Impact factor: 4.307

Review 9.  Colon cancer stem cells: implications for prevention and therapy.

Authors:  Emina H Huang; Max S Wicha
Journal:  Trends Mol Med       Date:  2008-10-17       Impact factor: 11.951

10.  Tracing cell fates in human colorectal tumors from somatic microsatellite mutations: evidence of adenomas with stem cell architecture.

Authors:  J L Tsao; J Zhang; R Salovaara; Z H Li; H J Järvinen; J P Mecklin; L A Aaltonen; D Shibata
Journal:  Am J Pathol       Date:  1998-10       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.